Ferring launched PENTASA® (mesalazine) for the treatment of inflammatory bowel diseases. This product enabled the company to strengthen its position in gastroenterology.
0 Kommentare
Antwort hinterlassen
Du musst angemeldet sein, um einen Kommentar zu schreiben.